Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
skip to main content
10.1145/3449258.3449262acmotherconferencesArticle/Chapter ViewAbstractPublication PagesiccbbConference Proceedingsconference-collections
research-article

A Framework for Route Based Pathway Analysis of Gene Expression Data

Published: 22 June 2021 Publication History

Abstract

Pathway analysis is a key step in genomics study to reduce the data complexity and associate prior biological knowledge. Over representation analysis (ORA), Functional class scoring (FCS), and Topology based (TB) analysis are considered as three generations of pathway analysis techniques. These methods only detect the differential activity of an entire pathway, thereby ignoring the importance of routes and sections within the pathway. A novel route-based pathway analysis framework, Route based Pathway Analysis in Cohorts (rPAC), is discussed in this paper which uses pathway topology in true sense by identifying and scoring individual routes within pathways. Activity scores and p-values are calculated for all signaling and effector routes from KEGG signaling pathways with transcriptomics data from each sample in the given cohort. Overall route activity in a cohort is assessed in terms of two summary metrics, “Proportion of Significance” (PS) and “Average Route Score” (ARS). A systematic evaluation based on large number of simulated data showed rPAC significantly outperforming the traditional pathway analysis methods. Case studies of three epithelial cancers from The Cancer Genome Atlas (TCGA) repository revealed that some pathway routes (e.g., tight junction, Th17 cell differentiation, adipocytokine signaling etc.) can notably differentiate cancer types, while other pathway routes that are related to lipid metabolism and adipocytes metabolism are co-regulated in different cancers. While most of the findings are corroborated by the current understanding of cancer biology, many previously uncharacterized mechanisms were identified by rPAC analysis, exhibiting the potential to yield new insights into cancer phenotypes.

References

[1]
A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander and J.P. Mesirov, "Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles," Proceedings of the National Academy of Sciences, vol. 102, pp. 15545-15550, 2005.
[2]
H. Ogata, S. Goto, K. Sato, W. Fujibuchi, H. Bono and M. Kanehisa, "KEGG: Kyoto Encyclopedia of Genes and Genomes," Nucleic Acids Research, vol. 27, pp. 29-34, Jan 1, 1999.
[3]
B. Jassal, "The reactome pathway knowledgebase," Nucleic Acids Research, vol. 48, pp. D498-D503, Jan 8, 2020.
[4]
A.L. Tarca, S. Draghici, P. Khatri, S.S. Hassan, P. Mittal, J. Kim, C.J. Kim, J.P. Kusanovic and R. Romero, "A novel signaling pathway impact analysis," Bioinformatics, vol. 25, pp. 75-82, Jan 1, 2009.
[5]
C.J. Vaske, S.C. Benz, J.Z. Sanborn, D. Earl, C. Szeto, J. Zhu, D. Haussler and J.M. Stuart, "Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM," Bioinformatics (Oxford, England), vol. 26, pp. i237-i245, Jun 15, 2010.
[6]
C. Liu, R. Lehtonen and S. Hautaniemi, "PerPAS," Tcbb, vol. 15, pp. 1022-1027, May 1, 2018.
[7]
T.M. Therneau and P.M. Grambsch, Modeling Survival Data: Extending the Cox Model, Springer-Verlag New York, 2020.
[8]
B.J. Coventry, P. Lee, D. Gibbs and D.N.J. Hart, "Dendritic cell density and activation status in human breast cancer – CD1a, CMRF-44, CMRF-56 and CD-83 expression," British Journal of Cancer, vol. 86, pp. 546-551, 2002.
[9]
C. Lee, L. Chen, C. Yu, W. Lin, V.C. Lin, C. Huang, T. Lu, S. Huang and B. Bao, "Prognostic Value of CD1B in Localised Prostate Cancer," International Journal of Environmental Research and Public Health, vol. 16, pp. 4723, 2019.
[10]
S. Qie and J.A. Diehl, "Cyclin D1, cancer progression, and opportunities in cancer treatment," J Mol Med, vol. 94, pp. 1313-1326, 2016.
[11]
N. Zaidi, L. Lupien, N.B. Kuemmerle, W.B. Kinlaw, J.V. Swinnen and K. Smans, "Lipogenesis and lipolysis: The pathways exploited by the cancer cells to acquire fatty acids," Progress in Lipid Research, vol. 52, pp. 585-589, 2013.
[12]
J.S. Hansen, S. de Maré, H.A. Jones, O. Göransson and K. Lindkvist-Petersson, "Visualization of lipid directed dynamics of perilipin 1 in human primary adipocytes," Scientific Reports, vol. 7, pp. 15011-14, 2017.
[13]
X. Zhao, J. Liu, S. Ge, C. Chen, S. Li, X. Wu, X. Feng, Y. Wang and D. Cai, "Saikosaponin A Inhibits Breast Cancer by Regulating Th1/Th2 Balance," Frontiers in Pharmacology, vol. 10, pp. 624, 2019.
[14]
X. Dai, T. Li, Z. Bai, Y. Yang, X. Liu, J. Zhan and B. Shi, "Breast cancer intrinsic subtype classification, clinical use and future trends," American Journal of Cancer Research, vol. 5, pp. 2929-2943, 2015.
[15]
E. Tomaskovic-Crook, E.W. Thompson and J.P. Thiery, "Epithelial to mesenchymal transition and breast cancer," Breast Cancer Research: BCR, vol. 11, pp. 213, 2009.
[16]
M.F. Mercogliano, S. Bruni, P.V. Elizalde and R. Schillaci, "Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer," Frontiers in Oncology, vol. 10, pp. 584, 2020.
[17]
D. Colussi, G. Brandi, F. Bazzoli and L. Ricciardiello, "Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention," International Journal of Molecular Sciences, vol. 14, pp. 16365-16385, Aug 7, 2013.
[18]
M.N. Vansaun, "Molecular Pathways: Adiponectin and Leptin Signaling in Cancer," Clinical Cancer Research, vol. 19, pp. 1926-1932, Apr 15, 2013.

Cited By

View all
  • (2022)Computational Pathways Analysis and Personalized Medicine in HER2-Positive Breast CancerCurrent Pharmacogenomics and Personalized Medicine10.2174/187569211966622040711404419:1(40-52)Online publication date: Apr-2022

Index Terms

  1. A Framework for Route Based Pathway Analysis of Gene Expression Data
          Index terms have been assigned to the content through auto-classification.

          Recommendations

          Comments

          Information & Contributors

          Information

          Published In

          cover image ACM Other conferences
          ICCBB '20: Proceedings of the 2020 4th International Conference on Computational Biology and Bioinformatics
          December 2020
          80 pages
          ISBN:9781450388443
          DOI:10.1145/3449258
          Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than the author(s) must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected].

          Publisher

          Association for Computing Machinery

          New York, NY, United States

          Publication History

          Published: 22 June 2021

          Permissions

          Request permissions for this article.

          Check for updates

          Author Tags

          1. TCGA data analysis
          2. topology and route-based pathway analysis

          Qualifiers

          • Research-article
          • Research
          • Refereed limited

          Conference

          ICCBB '20

          Contributors

          Other Metrics

          Bibliometrics & Citations

          Bibliometrics

          Article Metrics

          • Downloads (Last 12 months)6
          • Downloads (Last 6 weeks)1
          Reflects downloads up to 17 Oct 2024

          Other Metrics

          Citations

          Cited By

          View all
          • (2022)Computational Pathways Analysis and Personalized Medicine in HER2-Positive Breast CancerCurrent Pharmacogenomics and Personalized Medicine10.2174/187569211966622040711404419:1(40-52)Online publication date: Apr-2022

          View Options

          Get Access

          Login options

          View options

          PDF

          View or Download as a PDF file.

          PDF

          eReader

          View online with eReader.

          eReader

          HTML Format

          View this article in HTML Format.

          HTML Format

          Media

          Figures

          Other

          Tables

          Share

          Share

          Share this Publication link

          Share on social media